Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.

Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Abstract Text:

    p P ,s moussetS Mousset,a A ,d hoelzerD Hoelzer,j attaJ Atta,

    Primary plasma cell leukemia (PCL) is a rare hematologic disorder with distinct features. The criterion for the diagnosis of PCL is based on the finding of malignant plasma cells in the peripheral blood (more than 2 x 10(9)/L or more than 20% of white blood cells). We report a case of a 74-year-old patient with primary nonsecretory PCL. Examination of blood smears led to the diagnosis of PCL, which was confirmed by bone marrow biopsy. Due to the patient's impaired general condition, intensive chemotherapy could not be administered. After an oral induction chemotherapy consisting of cyclophosphamide and high dose dexamethasone followed by one cycle of high-dose dexamethasone and thalidomide no evidence of the disease in the peripheral blood was detectable. Consequently, the patient was put on a thalidomide maintenance therapy. Six months after first diagnosis, the patient was found to have bone marrow and peripheral blood relapse with anemia and neutropenia in the clinical context of acute on chronic renal failure. After a limited response to further chemotherapy, the patient died 14 months after the first diagnosis while on dexamethasone maintenance. We conclude that monotherapy with thalidomide might be an alternative maintenance strategy with limited response duration for patients with primary PCL in impaired general condition.

    Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Publishing Authors By Initials

    p P ,s moussetS Mousset,a A ,d hoelzerD Hoelzer,j attaJ Atta,

    For similar organic chemicals: carboxylic acids: acids, carbocyclic: phthalic acids: phthalimides: thalidomide research abstracts see: organic chemicals: carboxylic acids: acids, carbocyclic: phthalic acids: phthalimides: thalidomide research

    PUBMED ID PMID:

    MEDLINE DATE:

    Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: International journal of hematology

    VOLUME: 86

    Page Numbers: 66-8

    Journal Abbreviation: Int. J. Hematol.

    ISSN: 0925-5710

    DAY: 27

    MONTH: Jul

    YEAR: 2007

    Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9111627

    Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Keywords Mesh Terms:

    KEYWORDS: Thalidomide

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment. Information

    Substance Name: Thalidomide

    Registry Number: 50-35-1

    Grant and Affiliation Information for Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.

    AFFILIATION: Department of Hematology and Oncology, University Hospital of the Johann-Wolfgang-Goethe-University, Frankfurt, Germany. p.brueck@em.uni-frankfurt.de

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Hematol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News